Transgene (TNG) Financial Statements

7 Followers

Transgene Financial Overview

Transgene's market cap is currently €208.49M. The company's EPS TTM is €-0.26; its P/E ratio is -2.10; Transgene is scheduled to report earnings on April 29, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 137.00K	€ 6.35M	€ 7.90M	€ 3.13M	€ 9.99M
Gross Profit	€ 490.00K	€ -27.93M	€ -21.69M	€ -29.04M	€ -22.89M
Operating Income	€ -41.07M	€ -35.66M	€ -30.05M	€ -29.90M	€ -23.52M
EBITDA	€ -39.77M	€ -26.65M	€ -28.44M	€ -30.33M	€ -23.55M
Net Income	€ -37.52M	€ -33.97M	€ -22.33M	€ -32.81M	€ -20.00M
Balance Sheet
Cash & Short-Term Investments	€ 111.86M	€ 16.67M	€ 15.67M	€ 26.83M	€ 49.57M
Total Assets	€ 138.83M	€ 42.17M	€ 45.22M	€ 66.44M	€ 101.84M
Total Debt	€ 2.06M	€ 10.40M	€ 1.35M	€ 2.45M	€ 3.84M
Net Debt	€ -4.60M	€ -6.44M	€ -14.32M	€ -1.95M	€ -2.07M
Total Liabilities	€ 17.09M	€ 26.97M	€ 29.61M	€ 28.59M	€ 34.63M
Stockholders' Equity	€ 121.73M	€ 15.20M	€ 15.61M	€ 37.84M	€ 67.21M
Cash Flow
Free Cash Flow	€ -37.58M	€ -26.62M	€ -37.42M	€ -21.84M	€ -32.63M
Operating Cash Flow	€ -36.74M	€ -23.55M	€ -34.67M	€ -20.30M	€ -31.94M
Investing Cash Flow	€ -105.95M	€ -3.21M	€ 34.57M	€ 20.27M	€ 16.79M
Financing Cash Flow	€ 134.38M	€ 26.96M	€ 11.37M	€ -1.48M	€ 15.77M

Currency in EUR

Transgene Earnings and Revenue History

Income Statement >

Transgene Debt to Assets

Balance Sheet >

Transgene Cash Flow

Cash Flow >

Transgene Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >